The diffuse uniform thickening of glomerular basement membrane (GBM), the earliest pathological change in DN, were also prominently reduced by the anti-ANGPTL3/IL22 compared with anti-ANGPTL3 or mIL22 alone (P<0.01). The gene discussed is ANGPTL3; the disease is liver dysplastic nodule.